Large‐scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain

• Published in: The Journal of pathology 2010-12, Vol.222 (4), p.380-387
• Main Authors: de Marco, Mar Fernandez, Linehan, Jacqueline, Gill, O. Noel, Clewley, Jonathan P, Brandner, Sebastian
• Format: Article
• Language: English
• Subjects: Antibodies; Appendix; Biological and medical sciences; Bovine spongiform encephalopathy; Carrier State - epidemiology; Carrier State - metabolism; Cohort Studies; Creutzfeldt-Jakob disease; Creutzfeldt-Jakob Syndrome - epidemiology; Creutzfeldt-Jakob Syndrome - metabolism; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; England - epidemiology; Enzyme immunoassay; Epidemics; Follicles; Humans; Immunoblotting; Immunoenzyme Techniques; Immunohistochemistry; Investigative techniques, diagnostic techniques (general aspects); Medical sciences; Neurology; Palatine Tonsil - metabolism; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Prevalence; Prion protein; Prions - metabolism; PrP; Scotland - epidemiology; Tonsil; variant Creutzfeldt-Jakob disease; vCJD prevalence
• ISSN: 0022-3417; 1096-9896
• DOI: 10.1002/path.2767

There have been 173 cases of variant Creutzfeldt-Jakob disease (vCJD) in the UK, as of 5 July 2010, as a result of the bovine spongiform encephalopathy epidemic. The number of individuals subclinically infected with vCJD, and thus the eventual number of cases, remains, however, uncertain. In an attempt to address this problem, 63 007 tonsil tissue specimens were previously tested by enzyme immunoassay (EIA) for the presence of disease‐related prion protein (PrPres) and found to be negative. To confirm the reliability of this result, all those in the birth cohort most at risk (1961-1985) and a few others, including controls, have now been tested by immunohistochemistry (IHC). Histological slides were prepared from 10 075 anonymized formalin‐fixed, paraffin‐embedded tissues and examined for PrPres with two anti‐prion protein antibodies, ICMS35 and KG9. One specimen showed a single strongly positive follicle with both antibodies, on two slides from adjacent sections. As this specimen was negative when it was further investigated by EIA, IHC, and immunoblotting, it is unclear whether the patient from whom the tonsil came will go on to develop vCJD. If, however, this is the case, then a finding of 1 out of 9160 gives a prevalence of disease‐related prion protein in the British population of 109 per million, with a 95% confidence interval (CI) of 3-608 per million, which is not statistically different (exact p = 0.63) from population prevalence estimates based on finding three positives out of 10 278 in a previous IHC study of appendix tissue. If this is not the case, a finding of 0 out of 9160 gives a prevalence of 0-403 per million (95% CI) for the 1961‐1985 cohort, which is also not different (exact p = 0.25) from previous population prevalence estimates. Therefore, the results of this work could be summarized as finding, by IHC, no or one vCJD‐positive individual. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.